{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:42:11Z","timestamp":1791916931596,"version":"4.3.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>To the best of our knowledge, no case has been published in the literature that reports an overdose of tiapride, either alone or in combination with other drugs. We report a self-poisoning case in an 18-year-old girl, with approximately 10 times the usual daily dose (ie, 2.5 g). Although the blood concentration was 20\/30-fold higher than usually observed after therapeutic drug intakes (17,300 mcg\/L), the patient remained almost asymptomatic.<\/jats:p>","DOI":"10.1097\/ftd.0000000000000453","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T05:32:32Z","timestamp":1510291952000},"page":"581-583","source":"Crossref","is-referenced-by-count":3,"title":["Unsuccessful Suicide Attempt With Tiapride"],"prefix":"10.1097","volume":"39","author":[{"given":"Sylvain","family":"Couderc","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Mourou","sequence":"additional","affiliation":[{"name":"Emergency Unit, Hospital Centre of Carcassonne, Carcassonne, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Monchaud","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Saint-Marcoux","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","first-page":"1045","article-title":"The acute manifestations of alcoholism and their treatment (author's transl) [in French]","volume":"54","author":"L\u00e9ger","year":"1978","journal-title":"Sem Hop."},{"key":"R2-20230814","first-page":"2488","article-title":"Tiapride in acute stages of drug addiction [in French]","volume":"58","author":"Angeli","year":"1982","journal-title":"Sem Hop."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2165\/00002512-199303050-00007","article-title":"A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation","volume":"3","author":"Steele","year":"1993","journal-title":"Drugs Aging"},{"key":"R4-20230814","first-page":"2647","article-title":"Clinical experience with tiapride in the treatment of extrapyramidal syndromes [in French]","volume":"58","author":"Csanda","year":"1982","journal-title":"Sem Hop."},{"key":"R5-20230814","first-page":"222","article-title":"The possibility of pharmacologic therapy of extrapyramidal hyperkineses with tiapride [in German]","volume":"35","author":"Grass","year":"1983","journal-title":"Psychiatr Neurol Med Psychol (Leipz)."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1742-1241.2003.tb10446.x","article-title":"Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride","volume":"57","author":"Koch","year":"2003","journal-title":"Int J Clin Pract."},{"key":"R7-20230814","first-page":"2015","article-title":"Drug-induced hemichorea","author":"Watari","year":"2015","journal-title":"BMJ Case Rep."},{"key":"R8-20230814","first-page":"279","article-title":"Absorption, elimination and metabolism of a new neuroleptic agent (FLO 1347) in the rat dog and man (author's transl) [in French]","volume":"36","author":"Strolin-Benedetti","year":"1978","journal-title":"Ann Pharm Fr."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.jchromb.2011.10.032","article-title":"High-performance liquid chromatographic determination of tiapride and its phase I metabolite in blood plasma using tandem UV photodiode-array and fluorescence detection","volume":"879","author":"Nobilis","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9343(00)00564-7","article-title":"Tiapride-induced torsade de pointes","volume":"109","author":"Iglesias","year":"2000","journal-title":"Am J Med."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40264-015-0353-1","article-title":"The contribution of national spontaneous reporting systems to detect signals of torsadogenicity: issues emerging from the ARITMO project","volume":"39","author":"Raschi","year":"2016","journal-title":"Drug Saf."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF02455992","article-title":"Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease","volume":"32","author":"Norman","year":"1987","journal-title":"Eur J Clin Pharmacol."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00044011-199815050-00010","article-title":"A new oral formulation of tiapride (drops): pharmacokinetic profile and therapeutic applications","volume":"15","author":"Canal","year":"1998","journal-title":"Clin Drug Investig."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/jnnp.49.9.1055","article-title":"Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia","volume":"49","author":"Roos","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000118195","article-title":"Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations","volume":"14","author":"Greil","year":"1985","journal-title":"Neuropsychobiology"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jflm.2011.06.003","article-title":"An UPLC-MS\/MS method for the determination of valproic acid in blood of a fatal intoxication case","volume":"18","author":"Proen\u00e7a","year":"2011","journal-title":"J Forensic Leg Med."},{"key":"R18-20230814","first-page":"447","article-title":"Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics","volume":"58","author":"Schulz","year":"2003","journal-title":"Pharmazie"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2s011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.talanta.2007.11.060","article-title":"An improved HPLC method for rapid quantitation of diazepam and its major metabolites in human plasma","volume":"75","author":"Rouini","year":"2008","journal-title":"Talanta"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.euroneuro.2016.07.006","article-title":"Comparative risk of death in older adults treated with antipsychotics: a population-based cohort study","volume":"26","author":"Schmedt","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"R22-20230814","first-page":"785","article-title":"Ventricular arrhythmias treated by diazepam","volume":"98","author":"Van Loon","year":"1968","journal-title":"Can Med Assoc J."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0024-3205(91)90257-C","article-title":"Diazepam administered prior to coronary artery occlusion increases latency to ventricular fibrillation","volume":"49","author":"Pinto","year":"1991","journal-title":"Life Sci."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phrs.2009.03.003","article-title":"Mitochondrial benzodiazepine receptors mediate cardioprotection of estrogen against ischemic ventricular fibrillation","volume":"60","author":"Li","year":"2009","journal-title":"Pharmacol Res."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.yjmcc.2009.11.011","article-title":"Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization","volume":"48","author":"Brown","year":"2010","journal-title":"J Mol Cell Cardiol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007691-201712000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:20:00Z","timestamp":1785766800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201712000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000453","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}